Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...
The antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF. Tobramycin is an aminoglycoside antibiotic indicated for the treatment of serious bacterial ...
COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of ...
(RTTNews) - Integrated pharmaceutical company Dr. Reddy's Laboratories Ltd. (RDY) announced Tuesday the launch of Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of TOBI ...
September 5, 2011 — In a 13-to-1 vote, a US Food and Drug Administration (FDA) advisory panel today said that evidence supports the safety and efficacy of tobramycin inhalation powder (TIP; TOBI ...
Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...
Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients CHMP supports approval of TOBI Podhaler, a ...
The US Food and Drug Administration (FDA) approved a tobramycin inhalation powder (TOBI Podhaler, Novartis) for treating patients with cystic fibrosis (CF) whose lungs are infected with the bacterium ...
-Antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose ) announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results